Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

NCT02016690 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02016690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2015
Enrollment
312 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus infection